Lipid-Lowering Therapies: Risks in Women and Evidence-Based Options

DOI: 10.14503/THIJ-18-6691

Keywords: Anticholesteremic agents/therapeutic use, cardiovascular diseases/drug therapy/prevention & control, cholesterol, LDL/blood, diabetes mellitus, type 2/chemically induced, drug therapy, combination, female, hydroxymethylglutaryl-CoA reductase inhibitors/therapeutic use, randomized controlled trials as topic, sex factors, treatment outcome

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text